Literature DB >> 10069904

Isolated femoropopliteal bypass graft for limb salvage after failed tibial reconstruction: a viable alternative to amputation.

R H Samson1, D P Showalter, J P Yunis.   

Abstract

PURPOSE: Femoropopliteal bypass grafting procedures performed to isolated popliteal arteries after failure of a previous tibial reconstruction were studied. The results were compared with those of a study of primary isolated femoropopliteal bypass grafts (IFPBs).
METHODS: IFPBs were only constructed if the uninvolved or patent popliteal segment measured at least 7 cm in length and had at least one major collateral supplying the calf. When IFPB was performed for ischemic lesions, these lesions were usually limited to the digits or small portions of the foot. Forty-seven polytetrafluoroethylene grafts and three autogenous reversed saphenous vein grafts were used.
RESULTS: Ankle brachial pressure index (ABI) increased after bypass grafting by a mean of 0.46. Three-year primary life table patency and limb-salvage rates for primary IFPBs were 73% and 86%, respectively. All eight IFPBs performed after failed tibial bypass grafts remained patent for 2 to 44 months, with patients having viable, healed feet.
CONCLUSION: In the presence of a suitable popliteal artery and limited tissue necrosis, IFPB can have acceptable patency and limb-salvage rates, even when a polytetrafluoroethylene graft is used. Secondary IFPB can be used to achieve limb salvage after failed tibial bypass grafting.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069904     DOI: 10.1016/s0741-5214(99)70268-5

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  Critical Limb Ischemia.

Authors:  David L. Dawson; Ryan T. Hagino
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

2.  Critical limb ischemia.

Authors:  David L Dawson; Joseph L Mills
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.